Abstract:Allopurinol is an orally administered inhibitor of xanthine oxidase used primarily in the treatment of hyperuricemia associated with gout. Allopurinol reduces serum and urinary uric acid concentrations. Its use should be individualized for each patient. The dosage of allopurinol to accomplish full control of gout and to lower serum uric acid to normal or near-normal levels varies with the severity of the disease, and needs to be flexible to permit precise, customized dose titration for individual patients. This flexibility is readily achieved using an oral liquid dosage form. However, no commercial liquid dosage form of allopurinol currently exists. Allopurinol is commercially available as 100-mg and 300-mg scored tablets. An extemporaneously compounded suspension from pure drug powder or commercial tablets would provide a convenient option to meet unique patient needs. The purpose of this study was to determine the physicochemical stability of extemporaneously compounded allopurinol suspensions in the PCCA Base SuspendIt. This base is a sugar-free, paraben-free, dye-free, and gluten-free thixotropic vehicle containing a natural sweetener obtained from the monk fruit. The study design included two allopurinol concentrations to provide stability documentation over a bracketed concentration range for eventual use by compounding pharmacists. A robust stability-indicating ultra-performance liquid chromatography assay for the determination of the chemical stability of allopurinol in SuspendIt was developed and validated. Suspensions of allopurinol were prepared in SuspendIt at 10.0-mg/mL and 20.0-mg/mL concentrations, selected to represent a range within which the drug is commonly dosed. Samples were stored in plastic amber prescription bottles at two temperature conditions (5°C and 25°C). Samples were assayed initially and at the following time points: 7 days, 14 days, 30 days, 45 days, 60 days, 88 days, 120 days, and 182 days. Physical data such as pH, viscosity, and appearance were also noted. All measurements were obtained in triplicate. A stable extemporaneous product is defined as one that retains at least 90% of the initial drug concentration throughout the sampling period. The study showed that allopurinol concentrations did not go below 93% of the label claim (initial drug concentration) at both temperatures studied. Viscosity and pH values also did not change significantly. This study demonstrates that allopurinol is physically and chemically stable in SuspendIt for 180 days in the refrigerator and at room temperature, thus providing a viable, compounded alternative for allopurinol in a liquid dosage form, with an extended beyond-use-date to meet patient needs.

Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo

Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt

Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes

Quality-by-design case study: investigation of the role of poloxamer in immediate-release tablets by experimental design and multivariate data analysis

Novel pH-Sensitive Hydrogel Beads Based on Carrageenan and Fish Scale Collagen for Allopurinol Drug Delivery

Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.

Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF

Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol

Development and In vitro and In vivo Evaluations of a Microemulsion Formulation for the Oral Delivery of Oxaprozin

Encapsulation of Allopurinol by Glucose Cross-Linked Gelatin/zein Nanofibers: Characterization and Release Behavior

Investigation of Critical Core Formulation and Process Parameters for Osmotic Pump Oral Drug Delivery

Application of Box–Behnken Design to Optimize the Osmotic Drug Delivery System of Metoprolol Succinate and its In Vivo Evaluation in Beagle Dogs

Design and Evaluation of Bilayer Pump Tablet of Flurbiprofen Solid Dispersion for Zero-Order Controlled Delivery

Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout

Preparation of Monolithic Osmotic Pump Tablet of Poorly Soluble Atenolol

Fabrication of osmotic pump tablets utilizing semisolid extrusion three-dimensional printing technology

Development of Monolithic Osmotic Pump Tablet System for Isosorbide-5-Mononitrate Delivery and Evaluation of It in Vitro and in Vivo

A comparative study of the effect of different alkaline stabilizers on physicochemical properties of lansoprazole in formulation

Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe

Preparation of monolithic osmotic pump system by coating the indented core tablet.

In vitro and in vivo evaluation of ofloxacin sustained release pellets